300142 沃森生物
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.0281.5144.5508.2955.692
总资产报酬率 ROA (%)0.0180.9382.7125.0233.670
投入资产回报率 ROIC (%)0.0261.3914.1787.8035.471

边际利润分析
销售毛利率 (%)71.48479.69185.47488.01888.612
营业利润率 (%)-2.9373.42614.92521.61520.511
息税前利润/营业总收入 (%)-5.5254.51812.83519.80719.355
净利润/营业总收入 (%)-4.2586.18112.43018.44617.366

收益指标分析
经营活动净收益/利润总额(%)-241.074156.999160.534119.595117.808
价值变动净收益/利润总额(%)-94.792-50.576-38.004-17.519-31.436
营业外收支净额/利润总额(%)8.08547.603-2.503-2.707-0.188

偿债能力分析
流动比率 (X)3.2742.9822.7262.5502.374
速动比率 (X)2.9292.6642.4032.2662.104
资产负债率 (%)20.02121.84426.90128.34026.878
带息债务/全部投入资本 (%)2.4292.5894.1201.4260.063
股东权益/带息债务 (%)3,860.2553,603.8792,196.5716,535.940151,499.450
股东权益/负债合计 (%)327.973293.166222.946209.008230.844
利息保障倍数 (X)2.371-2.236-7.437-15.997-17.309

营运能力分析
应收账款周转天数 (天)466.118351.538292.173214.357233.085
存货周转天数 (天)499.654561.439611.627552.109619.485